Authorised representative (AR)

Lumenis (HK) Limited

Hong Kong MDACS·15 represented devices·4 applicants·Jan 09, 2013Oct 19, 2023
15
Total devices
4
Applicants
2013
First representation
2023
Most recent
AR overview
Bilingual authorised representative information and contact details
Authorised representative (EN)
Lumenis (HK) Limited
Phone
29607139
Timeline
First representation
Jan 09, 2013
Most recent
Oct 19, 2023
Risk class distribution
III
15
Applicant partnerships
Top manufacturers represented by this AR
Recent registrations
Latest 15 MDACS listings represented by Lumenis (HK) Limited
DeviceRisk classApplicantRegistered
Morcellators, Endoscopic
内窥镜下粉碎机
IIILumenis Ltd
Lumenis Inc.
Oct 19, 2023
Lasers, Carbon Dioxide, Surgical/Dermatologic
激光、二氧化碳、外科/皮肤科
IIILumenis Ltd.
Lumenis Inc.
Feb 17, 2021
Lasers, Carbon Dioxide, Surgical/Dermatologic
激光、二氧化碳、外科/皮肤科
IIILumenis Limited
Lumenis Inc.
Dec 06, 2018
Slit Lamps
裂隙灯
IIILumenis, Inc.
Lumenis, Inc.
Dec 06, 2018
Lasers, Ho:YAG
激光,Ho:YAG
IIILumenis Ltd.
Lumenis Inc.
Sep 22, 2018
Lasers, Nd:YAG, Ophthalmic
激光,Nd:YAG,眼科
IIILumenis, Inc.
Lumenis, Inc.
Aug 21, 2018
Lasers, Nd:YAG, Frequency-Doubled, Ophthalmic
激光,Nd:YAG,倍频,眼科
IIILumenis, Inc.
Lumenis, Inc.
May 16, 2018
Lasers, Diode
激光器,二极管
IIILumenis, Inc.
Lumenis, Inc.
Mar 08, 2013
Lasers, Ho:YAG
激光,Ho:YAG
IIILumenis Limited
Lumenis Inc.
Mar 01, 2013
Lasers, Ho:YAG
激光,Ho:YAG
IIILumenis Limited
Lumenis Inc.
Mar 01, 2013
Lasers, Carbon Dioxide, Surgical/Dermatologic
激光、二氧化碳、外科/皮肤科
IIILumenis Limited
Lumenis Inc.
Jan 25, 2013
Lasers, Carbon Dioxide, Surgical/Dermatologic
激光、二氧化碳、外科/皮肤科
IIILumenis Limited
Lumenis Inc.
Jan 25, 2013
Lasers, Carbon Dioxide, Surgical/Dermatologic
激光、二氧化碳、外科/皮肤科
IIILumenis Limited
Lumenis Inc.
Jan 25, 2013
Lasers, Diode
激光器,二极管
IIILumenis Limited
Lumenis Inc.
Jan 25, 2013
Lasers, Nd:YAG, Ophthalmic
激光,Nd:YAG,眼科
IIILumenis, Inc.
Lumenis, Inc.
Jan 09, 2013
About this profile

Lumenis (HK) Limited serves as the authorised representative for 15 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.